ethylenediamine has been researched along with Alzheimer Disease in 1 studies
ethylenediamine: RN given refers to parent cpd; edamine is the recommended contraction for the ethylenediamine radical
ethylenediamine : An alkane-alpha,omega-diamine in which the alkane is ethane.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "An important part of pathogenesis of Alzheimer's disease (AD) is attributed to the contribution of AGE (Advanced Glycation Endproducts) and ALE (Advanced Lipid peroxidation Endproducts)." | 1.43 | Multifunctional diamine AGE/ALE inhibitors with potential therapeutical properties against Alzheimer's disease. ( Boullier, A; Lohou, E; Sasaki, NA; Sonnet, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lohou, E | 1 |
| Sasaki, NA | 1 |
| Boullier, A | 1 |
| Sonnet, P | 1 |
1 other study available for ethylenediamine and Alzheimer Disease
| Article | Year |
|---|---|
Multifunctional diamine AGE/ALE inhibitors with potential therapeutical properties against Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Copper; Diamines; Glycation | 2016 |